So, in the present study, we conducted the model of hepatic steatosis to investigated whether SCD1 could control lipophagy via AMPK to regulate hepatic lipogenesis so as to explore the mechanism and the potential therapeutic target of NAFLD. This evidence concerns the gene SCD and Hepatic steatosis.